Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Yaroustovsky, Michail ^a   Plyushch, Marina ^a   Popov, Dmitry ^a   Samsonova, Natalia ^a   Abramyan, Marina ^a   Popok, Zakhar ^a   Krotenko, Nickolay ^a  

^a Bakoulev Scientific Centre for Cardiovascular Surgery   (Russian Federation)

Author keywords

Cardiac surgery; Endotoxin; Endotoxin activity assay; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; ENDOTOXIN;

ADULT; AGED; APACHE; ARTICLE; BIOASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTOXIN ACTIVITY ASSAY; FEMALE; GRAM NEGATIVE SEPSIS; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

NEGIBACTERIA;

EID: 84874533572     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-8     Document Type: Article

References (17)

1. Endotoxins and other sepsis triggers. Opal SM, Contrib Nephrol 2010 167 14 24 20519895
2. Bacterial endotoxin testing: a report on the methods, background, data, and regulatory history of extraction recovery efficiency. Bryans TD, Braithwaite C, Broad J, Cooper JF, Darnell KR, Hitchins VM, Karren AJ, Lee PS, Biomed Instrum Technol 2004 38 1 73 78 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2 15008051 (Pubitemid 38233288)
3. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, Romaschin AD, Derzko AN, Crit Care 2002 6 4 342 382 10.1186/cc1522 12225611 (Pubitemid 34863703)
4. MEDIC study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A, J Infect Dis 2004 190 3 527 534 10.1086/422254 15243928 (Pubitemid 38982092)
5. Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, Marshall JC, Shock 2007 28 5 524 529 17589381 (Pubitemid 350287436)
6. Klein D, Clinical assessment does not predict endotoxemia in septic shock [abstract 469] Miami (FL): Programs and abstracts of the Society of Critical Care Medicine 2010 January 9-13
7. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, Crit Care Med 2008 36 1 296 327 10.1097/01.CCM.0000298158.12101.41 18158437
8. Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery. Blomquist S, Gustafsson V, Manolopoulos T, Pierre L, Perfusion 2009 24 1 13 17 10.1177/0267659109106730 19567543
9. Preliminary report regarding the use of selective sorbents in complex cardiac surgery patients with extensive sepsis and prolonged intensive care stay. Yaroustovsky M, Abramyan M, Popok Z, Nazarova E, Stupchenko O, Popov D, Plushch M, Samsonova N, Blood Purif 2009 28 3 227 233 10.1159/000231988 19684388
10. Meisner M, Procalcitonin (PCT) A new, innovative infection parameter. Biochemical and clinical aspects Stuttgart: Georg Thieme Verlag 2000
11. Gut barrier dysfunction and sepsis. Fink MP, Aranow JS, Sepsis and Multiorgan Failure Baltimore, MD: Williams & Wilkins, Fein AM, Abraham ED, Balk RA, Bernard GR, Bone RC, Dantzker DR, Fink MP, 1997 383 407
12. Role of translocation of pathogen-associated molecular patterns in sepsis. Tsujimoto H, Ono S, Mochizuki H, Dig Surg 2009 26 2 100 109 10.1159/000206143 19252406
13. Bench-to-bedside review: Clinical experience with the endotoxin activity assay. Romaschin AD, Klein DJ, Marshall JC, Crit Care 2012 16 6 248 10.1186/cc11495 23206992
14. Why measure endotoxin in septic shock patients? Monti G, Colombo S, Mininni M, Terzi V, Ortisi GM, Vesconi S, Casella G, Crit Care 2008 12 Suppl 2 190 http://ccforum.com/content/12/S2/P190 10.1186/cc6411
15. Selective hemoperfusion in complex intensive care for severe sepsis and septic shock in patients after cardiac surgery. Yaroustovsky M, Abramyan M, Popok Z, Popov D, Plusch M, Nazarova E, Stupchenko O, Abstr 23rd ESICM Annu Congr-Barcelona, Spain 9-13 October 2010, E-poster #421
16. Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients. Monti G, Terzi V, Mininni M, Colombo S, Vesconi S, Casella G, Crit Care 2008 12 Suppl 2 458 http://ccforum.com/content/12/S2/P458 10.1186/cc6679
17. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C, JAMA 2009 301 23 2445 2452 10.1001/jama.2009.856 19531784